Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.

Villunger, A; Egle, A; Kos, M; Hartmann, BL; Geley, S; Kofler, R; Greil, R; Cancer Res. 1997; 57(16): 3331-3334.

Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.

Thaler, J; Hilbe, W; Apfelbeck, U; Linkesch, W; Sill, H; Seewann, H; Pont, J; Bernhart, M; Stöger, M; Niessner, H; Abbrederis, K; Geissler, D; Hausmaninger, H; Lin, W; Ludwig, H; Lang, A; Duba, C; Fluckinger, T; Greil, R; Grünewald, K; Konwalinka, G; Niederwieser, D; Fridrik, M; Leuk Res. 1997; 21(1):75-80

Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin“s lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor Therapy.

Fridrik, MA; Greil, R; Hausmaninger, H; Krieger, O; Oppitz, P; Stöger, M; Klocker, J; Neubauer, M; Helm, W; Pont, J; Fazeny, B; Hudec, M; Simonitsch, I; Radaszkiewicz, T; Ann Hematol. 1997; 75(4):135-140

Cytokine priming of the granulocyte respiratory burst in myelodysplastic syndromes.

Zabernigg, A; Hilbe, W; Eisterer, W; Greil, R; Ludescher, C; Thaler, J; Leuk Lymphoma. 1997; 27(1-2):137-143

The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells.

Geley, S; Hartmann, BL; Kapelari, K; Egle, A; Villunger, A; Heidacher, D; Greil, R; Auer, B; Kofler, R; FEBS Lett. 1997; 402(1): 36-40.

Inversion of CD4(+)/CD8(+) ratio in B chronic lymphocytic leukemia correlates with differential sensitivity of CD4(+) and CD8(+) T lymphocytes to the killing efficacy of Fas (APO-1/CD95) ligand(+) tumor cells.

Tinhofer, I; Marschitz, I; Kos, M; Henn, T; Egle, A; Villunger, A; Greil, R BLOOD. 1998; 92(10): 271B-271B.

Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial.

Krajnik, G; Wein, W; Greil, R; Marhold, F; Mohn-Staudner, A; Kummer, F; Malayeri, R; Zöchbauer-Müller, S; Huber, H; Pirker, R; Eur J Cancer. 1998; 34(12): 1977-1980.

Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemia.

Hilbe, W; Apfelbeck, U; Fridrik, M; Bernhart, M; Niessner, H; Abbrederis, K; Michlmayr, G; Pont, J; Linkesch, W; Hausmaninger, H; Arneitz, K; Baldinger, C; Duba, C; Eisterer, W; Greil, R; Konwalinka, G; Niederwieser, D; Gastl, G; Thaler, J; Leuk Res. 1998; 22(10): 881-886.

Prognosis and management strategies of lymphatic neoplasias in the elderly. II. Hodgkin“s disease.

Greil, R; Oncology. 1998; 55(4): 265-275.

Prognosis and management strategies of lymphatic neoplasias in the elderly. I. Aggressive non-Hodgkin“s lymphomas.

Greil, R; Oncology. 1998; 55(3): 189-217.